Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Atipamezole Hydrochloride
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Orion Corporation
Deal Size : Inapplicable
Deal Type : Inapplicable
Competition With Striatal [11C]ORM-13070 Binding by Atipamezole and Endogenous Noradrenaline
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
September 16, 2011
Lead Product(s) : Atipamezole Hydrochloride
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Orion Corporation
Deal Size : Inapplicable
Deal Type : Inapplicable